Search research articles
Contact Us
Filters
Showing results (131-140 of 2,131) with videos related to
Page
of 214
Sort By:
Clinical Chemistry
|
February 17, 2019
Measurement of Treatment Effects Requires Instruments Responsive to Change Based on the Minimal Important Difference
Bradley C Johnston, Gordon H Guyatt
Journal of Clinical Epidemiology
|
October 9, 2022
Evidence, values, and masks for control of COVID-19: 2 years later
Benjamin Djulbegovic, Iztok Hozo, Gordon Guyatt
Tropical Medicine & International Health : TM & IH
|
July 10, 1998
An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model
H L Guyatt, M S Chan
Chest
|
October 1, 1987
Rigorous evaluation. Greater need than ever
G H Guyatt, M T Newhouse
JAMA Internal Medicine
|
September 8, 2018
A Randomized Clinical Trial of n-of-1 Trials-Tribulations of a Trial
Reza D Mirza, Gordon H Guyatt
International Journal of Technology Assessment in Health Care
|
December 11, 1984
The ethics and feasibility of randomized trials of diagnostic technology: a reply
G H Guyatt, M F Drummond
ACP Journal Club
|
February 7, 2002
Review: albumin administration is not associated with excess mortality in acutely ill patients
Deborah J Cook, Gordon H Guyatt
Chest
|
February 7, 2001
The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians
J Hirsh, J Dalen, G Guyatt, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
January 31, 2002
Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa
H L Guyatt, R W Snow
Pharmacoeconomics
|
November 3, 1997
Reassessing quality-of-life instruments in the evaluation of new drugs
G H Guyatt, R J Jaeschke
Page
of 214
Search research articles
Search
Showing results (131-140 of 2,131) with videos related to
Sort By:
Page
of 214
Clinical Chemistry
|
February 17, 2019
Measurement of Treatment Effects Requires Instruments Responsive to Change Based on the Minimal Important Difference
Bradley C Johnston, Gordon H Guyatt
Journal of Clinical Epidemiology
|
October 9, 2022
Evidence, values, and masks for control of COVID-19: 2 years later
Benjamin Djulbegovic, Iztok Hozo, Gordon Guyatt
Tropical Medicine & International Health : TM & IH
|
July 10, 1998
An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model
H L Guyatt, M S Chan
Chest
|
October 1, 1987
Rigorous evaluation. Greater need than ever
G H Guyatt, M T Newhouse
JAMA Internal Medicine
|
September 8, 2018
A Randomized Clinical Trial of n-of-1 Trials-Tribulations of a Trial
Reza D Mirza, Gordon H Guyatt
International Journal of Technology Assessment in Health Care
|
December 11, 1984
The ethics and feasibility of randomized trials of diagnostic technology: a reply
G H Guyatt, M F Drummond
ACP Journal Club
|
February 7, 2002
Review: albumin administration is not associated with excess mortality in acutely ill patients
Deborah J Cook, Gordon H Guyatt
Chest
|
February 7, 2001
The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians
J Hirsh, J Dalen, G Guyatt, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
January 31, 2002
Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa
H L Guyatt, R W Snow
Pharmacoeconomics
|
November 3, 1997
Reassessing quality-of-life instruments in the evaluation of new drugs
G H Guyatt, R J Jaeschke
Page
of 214